Affymetrix, Nanosphere Lead the Way as Stocks Rebound in March | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix and Nanosphere were the two greatest beneficiaries of a rebound in March for stocks in the GenomeWeb Daily News Index.

Shares of both firms gained just over 50 percent in March, as stocks across the board rebounded from a very poor February, in which the Index had dropped 6 percent and the Dow Jones Industrial Average had fallen 12 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.